TIPRL and hepatocellular carcinoma: Given our previous report that TIPRL confers a TRAIL resistant property to hepatocellular carcinomas (HCCs)4, we examined levels of TIPRL as well as LC311 and CD13312, which are markers for autophagy and cancer stem cells (CSCs), respectively: all contributing to chemo- and radio-resistance in liver cancers.